The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes.
The global Cancer Vaccines market was valued at US$ 4755.6 million in 2023 and is anticipated to reach US$ 12220 million by 2030, witnessing a CAGR of 14.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cancer Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Vaccines.
Report Scope
The Cancer Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Glaxosmithkline
- Astellas Pharma
- Merck
- CSL Limited
- Sanpower Group
- Sanofi Pasteur
- Pfizer
- Serum Institute of India
Segment by Type
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccines
Segment by Application
- Cervical Cancer
- Prostate Cancer
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cancer Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cancer Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Cancer Vaccines Market Overview
1.1 Product Overview and Scope of Cancer Vaccines
1.2 Cancer Vaccines Segment by Type
1.2.1 Global Cancer Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Preventive Cancer Vaccines
1.2.3 Therapeutic Cancer Vaccines
1.3 Cancer Vaccines Segment by Application
1.3.1 Global Cancer Vaccines Market Value by Application: (2024-2030)
1.3.2 Cervical Cancer
1.3.3 Prostate Cancer
1.3.4 Others
1.4 Global Cancer Vaccines Market Size Estimates and Forecasts
1.4.1 Global Cancer Vaccines Revenue 2019-2030
1.4.2 Global Cancer Vaccines Sales 2019-2030
1.4.3 Global Cancer Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cancer Vaccines Market Competition by Manufacturers
2.1 Global Cancer Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cancer Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cancer Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Cancer Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cancer Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cancer Vaccines, Product Type & Application
2.7 Cancer Vaccines Market Competitive Situation and Trends
2.7.1 Cancer Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cancer Vaccines Players Market Share by Revenue
2.7.3 Global Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cancer Vaccines Retrospective Market Scenario by Region
3.1 Global Cancer Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cancer Vaccines Global Cancer Vaccines Sales by Region: 2019-2030
3.2.1 Global Cancer Vaccines Sales by Region: 2019-2024
3.2.2 Global Cancer Vaccines Sales by Region: 2025-2030
3.3 Global Cancer Vaccines Global Cancer Vaccines Revenue by Region: 2019-2030
3.3.1 Global Cancer Vaccines Revenue by Region: 2019-2024
3.3.2 Global Cancer Vaccines Revenue by Region: 2025-2030
3.4 North America Cancer Vaccines Market Facts & Figures by Country
3.4.1 North America Cancer Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cancer Vaccines Sales by Country (2019-2030)
3.4.3 North America Cancer Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cancer Vaccines Market Facts & Figures by Country
3.5.1 Europe Cancer Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cancer Vaccines Sales by Country (2019-2030)
3.5.3 Europe Cancer Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cancer Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Cancer Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cancer Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Cancer Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cancer Vaccines Market Facts & Figures by Country
3.7.1 Latin America Cancer Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cancer Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Cancer Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cancer Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Cancer Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cancer Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cancer Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cancer Vaccines Sales by Type (2019-2030)
4.1.1 Global Cancer Vaccines Sales by Type (2019-2024)
4.1.2 Global Cancer Vaccines Sales by Type (2025-2030)
4.1.3 Global Cancer Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Cancer Vaccines Revenue by Type (2019-2030)
4.2.1 Global Cancer Vaccines Revenue by Type (2019-2024)
4.2.2 Global Cancer Vaccines Revenue by Type (2025-2030)
4.2.3 Global Cancer Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Cancer Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cancer Vaccines Sales by Application (2019-2030)
5.1.1 Global Cancer Vaccines Sales by Application (2019-2024)
5.1.2 Global Cancer Vaccines Sales by Application (2025-2030)
5.1.3 Global Cancer Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Cancer Vaccines Revenue by Application (2019-2030)
5.2.1 Global Cancer Vaccines Revenue by Application (2019-2024)
5.2.2 Global Cancer Vaccines Revenue by Application (2025-2030)
5.2.3 Global Cancer Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Cancer Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Glaxosmithkline
6.1.1 Glaxosmithkline Corporation Information
6.1.2 Glaxosmithkline Description and Business Overview
6.1.3 Glaxosmithkline Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Glaxosmithkline Cancer Vaccines Product Portfolio
6.1.5 Glaxosmithkline Recent Developments/Updates
6.2 Astellas Pharma
6.2.1 Astellas Pharma Corporation Information
6.2.2 Astellas Pharma Description and Business Overview
6.2.3 Astellas Pharma Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Astellas Pharma Cancer Vaccines Product Portfolio
6.2.5 Astellas Pharma Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Cancer Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 CSL Limited
6.4.1 CSL Limited Corporation Information
6.4.2 CSL Limited Description and Business Overview
6.4.3 CSL Limited Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSL Limited Cancer Vaccines Product Portfolio
6.4.5 CSL Limited Recent Developments/Updates
6.5 Sanpower Group
6.5.1 Sanpower Group Corporation Information
6.5.2 Sanpower Group Description and Business Overview
6.5.3 Sanpower Group Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanpower Group Cancer Vaccines Product Portfolio
6.5.5 Sanpower Group Recent Developments/Updates
6.6 Sanofi Pasteur
6.6.1 Sanofi Pasteur Corporation Information
6.6.2 Sanofi Pasteur Description and Business Overview
6.6.3 Sanofi Pasteur Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Pasteur Cancer Vaccines Product Portfolio
6.6.5 Sanofi Pasteur Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Cancer Vaccines Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Serum Institute of India
6.8.1 Serum Institute of India Corporation Information
6.8.2 Serum Institute of India Description and Business Overview
6.8.3 Serum Institute of India Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Serum Institute of India Cancer Vaccines Product Portfolio
6.8.5 Serum Institute of India Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cancer Vaccines Industry Chain Analysis
7.2 Cancer Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cancer Vaccines Production Mode & Process
7.4 Cancer Vaccines Sales and Marketing
7.4.1 Cancer Vaccines Sales Channels
7.4.2 Cancer Vaccines Distributors
7.5 Cancer Vaccines Customers
8 Cancer Vaccines Market Dynamics
8.1 Cancer Vaccines Industry Trends
8.2 Cancer Vaccines Market Drivers
8.3 Cancer Vaccines Market Challenges
8.4 Cancer Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
